Michelle R. Ryan
|
Director |
Sale of securities on an exchange or to another person at price $ 59.70 per share. |
11 Nov 2024 |
2,800 |
10,835
(0%)
|
0%
|
59.7 |
167,160
|
Common Stock |
Donald Eugene Morel
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Oct 2024 |
4,663 |
70,118
(0%)
|
0%
|
|
0
|
Common Stock |
Jack L. Stahl
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Oct 2024 |
4,663 |
47,984
(0%)
|
0%
|
|
0
|
Common Stock |
Gregory T. Lucier
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Oct 2024 |
4,663 |
36,914
(0%)
|
0%
|
|
0
|
Common Stock |
Rolf A. Classon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Oct 2024 |
4,663 |
47,984
(0%)
|
0%
|
|
0
|
Common Stock |
J. Martin Carroll
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Oct 2024 |
4,663 |
32,734
(0%)
|
0%
|
|
0
|
Common Stock |
Stephanie S. Okey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Oct 2024 |
4,663 |
12,635
(0%)
|
0%
|
|
0
|
Common Stock |
Michael J. Barber
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Oct 2024 |
4,663 |
18,052
(0%)
|
0%
|
|
0
|
Common Stock |
Steven K. Barg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Oct 2024 |
4,663 |
12,374
(0%)
|
0%
|
|
0
|
Common Stock |
Michelle R. Ryan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Oct 2024 |
4,663 |
13,635
(0%)
|
0%
|
|
0
|
Common Stock |
Joseph A. Ferraro
|
SVP, General Counsel, CCO |
Sale of securities on an exchange or to another person at price $ 59.97 per share. |
18 Oct 2024 |
320 |
23,967
(0%)
|
0%
|
60.0 |
19,190
|
Common Stock |
David McErlane
|
Group President, Biologics |
Sale of securities on an exchange or to another person at price $ 59.97 per share. |
26 Sep 2024 |
1,994 |
36,304
(0%)
|
0%
|
60.0 |
119,580
|
Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Sale of securities on an exchange or to another person at price $ 59.55 per share. |
02 Aug 2024 |
1,169 |
113,724
(0%)
|
0%
|
59.6 |
69,614
|
Common Stock |
Lisa Evoli
|
SVP, Chief HR Officer |
Sale of securities on an exchange or to another person at price $ 59.67 per share. |
02 Aug 2024 |
3,859 |
39,366
(0%)
|
0%
|
59.7 |
230,267
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 59.55 per share. |
02 Aug 2024 |
666 |
39,635
(0%)
|
0%
|
59.5 |
39,660
|
Common Stock |
Joseph A. Ferraro
|
SVP, General Counsel, CCO |
Sale of securities on an exchange or to another person at price $ 59.58 per share. |
02 Aug 2024 |
608 |
24,287
(0%)
|
0%
|
59.6 |
36,225
|
Common Stock |
Ricky Hopson
|
Pres. BioProduct Delivery, CoS |
Sale of securities on an exchange or to another person at price $ 59.56 per share. |
02 Aug 2024 |
662 |
29,974
(0%)
|
0%
|
59.6 |
39,429
|
Common Stock |
John J. Greisch
|
Director, Executive Chair |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2024 |
63,736 |
79,932
(0%)
|
0%
|
|
0
|
Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Sale of securities on an exchange or to another person at price $ 58.70 per share. |
26 Jul 2024 |
349 |
114,893
(0%)
|
0%
|
58.7 |
20,486
|
Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2024 |
18,746 |
115,242
(0%)
|
0%
|
|
0
|
Common Stock |
Lisa Evoli
|
SVP, Chief HR Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2024 |
15,338 |
43,225
(0%)
|
0%
|
|
0
|
Common Stock |
Alessandro Maselli
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 58.76 per share. |
26 Jul 2024 |
9,088 |
177,521
(0%)
|
0%
|
58.8 |
534,011
|
Common Stock |
Alessandro Maselli
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2024 |
98,671 |
186,609
(0%)
|
0%
|
|
0
|
Common Stock |
Matti Masanovich
|
SVP, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2024 |
42,604 |
76,475
(0%)
|
0%
|
|
0
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2024 |
11,078 |
40,584
(0%)
|
0%
|
|
0
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 58.69 per share. |
26 Jul 2024 |
283 |
40,301
(0%)
|
0%
|
58.7 |
16,609
|
Common Stock |
Joseph A. Ferraro
|
SVP, General Counsel, CCO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2024 |
17,042 |
24,895
(0%)
|
0%
|
|
0
|
Common Stock |
Michael J. Hatzfeld
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2024 |
5,624 |
13,532
(0%)
|
0%
|
|
0
|
Common Stock |
Ricky Hopson
|
Pres. BioProduct Delivery, CoS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2024 |
10,225 |
30,842
(0%)
|
0%
|
|
0
|
Common Stock |
Ricky Hopson
|
Pres. BioProduct Delivery, CoS |
Sale of securities on an exchange or to another person at price $ 58.67 per share. |
26 Jul 2024 |
206 |
30,636
(0%)
|
0%
|
58.7 |
12,086
|
Common Stock |
David McErlane
|
Group President, Biologics |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2024 |
18,746 |
38,298
(0%)
|
0%
|
|
0
|
Common Stock |
Matti Masanovich
|
SVP, Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 56.74 per share. |
08 Jul 2024 |
2,993 |
33,871
(0%)
|
0%
|
56.7 |
169,823
|
Common Stock |
Ricky Hopson
|
Pres. BioProduct Delivery, CoS |
Sale of securities on an exchange or to another person at price $ 54.26 per share. |
04 Jun 2024 |
1,401 |
20,617
(0%)
|
0%
|
54.3 |
76,023
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 56.20 per share. |
15 Mar 2024 |
387 |
29,506
(0%)
|
0%
|
56.2 |
21,749
|
Common Stock |
Kreuzburg Christa
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.41 per share. |
25 Jan 2024 |
523 |
18,283
(0%)
|
0%
|
50.4 |
26,364
|
Common Stock |
Hatzfeld J. Michael
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2024 |
3,981 |
3,981
|
-
|
|
-
|
Options to purchase Common Stock |
Michael Hatzfeld J.
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2024 |
1,837 |
1,837
(0%)
|
0%
|
|
0
|
Common Stock |
J. Hatzfeld Michael
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2024 |
6,071 |
7,908
(0%)
|
0%
|
|
0
|
Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2023 |
1,505 |
96,863
(0%)
|
0%
|
|
0
|
Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.18 per share. |
08 Dec 2023 |
367 |
96,496
(0%)
|
0%
|
37.2 |
13,645
|
Common Stock |
Hopson Ricky
|
Pres. Clinical Dev Supply Div |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.18 per share. |
08 Dec 2023 |
256 |
22,018
(0%)
|
0%
|
37.2 |
9,518
|
Common Stock |
Hopson Ricky
|
Pres. Clinical Dev Supply Div |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2023 |
747 |
22,274
(0%)
|
0%
|
|
0
|
Common Stock |
Gunther Scott
|
SVP, Quality & Reg. Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2023 |
1,023 |
30,143
(0%)
|
0%
|
|
0
|
Common Stock |
Maselli Alessandro
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2023 |
3,761 |
89,862
(0%)
|
0%
|
|
0
|
Common Stock |
Maselli Alessandro
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.18 per share. |
08 Dec 2023 |
1,924 |
87,938
(0%)
|
0%
|
37.2 |
71,534
|
Common Stock |
Gunther Scott
|
SVP, Quality & Reg. Affairs |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.18 per share. |
08 Dec 2023 |
250 |
29,893
(0%)
|
0%
|
37.2 |
9,295
|
Common Stock |
Donald E. Morel
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2023 |
6,993 |
65,455
(0%)
|
0%
|
|
0
|
Common Stock |
Jack L. Stahl
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2023 |
6,993 |
43,321
(0%)
|
0%
|
|
0
|
Common Stock |
Gregory T. Lucier
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2023 |
6,993 |
32,251
(0%)
|
0%
|
|
0
|
Common Stock |
Rolf A. Classon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2023 |
6,993 |
43,321
(0%)
|
0%
|
|
0
|
Common Stock |
Madhu Balachandran
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2023 |
6,993 |
27,441
(0%)
|
0%
|
|
0
|
Common Stock |
Rosemary A. Crane
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2023 |
6,993 |
23,873
(0%)
|
0%
|
|
0
|
Common Stock |
Karen A. Flynn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2023 |
6,993 |
24,339
(0%)
|
0%
|
|
0
|
Common Stock |
J. Martin Carroll
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2023 |
6,993 |
28,071
(0%)
|
0%
|
|
0
|
Common Stock |
Christa Kreuzburg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2023 |
6,993 |
20,051
(0%)
|
0%
|
|
0
|
Common Stock |
Christa Kreuzburg
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.32 per share. |
27 Oct 2023 |
1,245 |
18,806
(0%)
|
0%
|
39.3 |
48,953
|
Common Stock |
Stephanie S. Okey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2023 |
6,993 |
7,972
(0%)
|
0%
|
|
0
|
Common Stock |
Michael J. Barber
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2023 |
6,993 |
13,389
(0%)
|
0%
|
|
0
|
Common Stock |
Steven K. Barg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2023 |
6,993 |
7,711
(0%)
|
0%
|
|
0
|
Common Stock |
Michelle R. Ryan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2023 |
6,993 |
8,972
(0%)
|
0%
|
|
0
|
Common Stock |
Ferraro A. Joseph
|
SVP, General Counsel, CCO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Oct 2023 |
5,902 |
5,902
|
-
|
|
-
|
Options to purchase Common Stock |
Joseph A. Ferraro
|
SVP, General Counsel, CCO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Oct 2023 |
2,708 |
7,853
(0%)
|
0%
|
|
0
|
Common Stock |
Patricia Josephine Anne Hunt
|
Pres. Consumer Health Div |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.50 per share. |
16 Oct 2023 |
22 |
11,267
(0%)
|
0%
|
46.5 |
1,023
|
Common Stock |
Steven K. Barg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Sep 2023 |
718 |
718
(0%)
|
0%
|
|
0
|
Common Stock |
Michelle R. Ryan
|
Director |
Purchase of securities on an exchange or from another person at price $ 49.98 per share. |
31 Aug 2023 |
1,000 |
1,979
(0%)
|
0%
|
50.0 |
49,980
|
Common Stock |
John J. Greisch
|
Director, Executive Chair |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Aug 2023 |
127,096 |
127,096
|
-
|
|
-
|
Options to purchase Common Stock |
John J. Greisch
|
Director, Executive Chair |
Purchase of securities on an exchange or from another person at price $ 50.24 per share. |
30 Aug 2023 |
21,000 |
34,000
(0%)
|
0%
|
50.2 |
1,055,040
|
Common Stock |
Stephanie S. Okey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Aug 2023 |
979 |
979
(0%)
|
0%
|
|
0
|
Common Stock |
Michelle R. Ryan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Aug 2023 |
979 |
979
(0%)
|
0%
|
|
0
|
Common Stock |
Steven L. Fasman
|
EVP & Chief Admin Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Aug 2023 |
2,226 |
74,327
(0%)
|
0%
|
|
0
|
Common Stock |
Steven L. Fasman
|
EVP & Chief Admin Officer |
Sale of securities on an exchange or to another person at price $ 44.65 per share. |
23 Aug 2023 |
817 |
73,789
(0%)
|
0%
|
44.6 |
36,479
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Sale of securities on an exchange or to another person at price $ 44.50 per share. |
23 Aug 2023 |
390 |
24,449
(0%)
|
0%
|
44.5 |
17,355
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Aug 2023 |
1,114 |
24,839
(0%)
|
0%
|
|
0
|
Common Stock |
Patricia Josephine Anne Hunt
|
Pres. Consumer Health Div |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Aug 2023 |
289 |
11,395
(0%)
|
0%
|
|
0
|
Common Stock |
Patricia Josephine Anne Hunt
|
Pres. Consumer Health Div |
Sale of securities on an exchange or to another person at price $ 44.77 per share. |
23 Aug 2023 |
106 |
11,289
(0%)
|
0%
|
44.8 |
4,746
|
Common Stock |
Jonathan Arnold
|
SVP, CCO & Div. Head BioP Del. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Aug 2023 |
1,590 |
57,486
(0%)
|
0%
|
|
0
|
Common Stock |
Jonathan Arnold
|
SVP, CCO & Div. Head BioP Del. |
Sale of securities on an exchange or to another person at price $ 44.87 per share. |
23 Aug 2023 |
87 |
57,399
(0%)
|
0%
|
44.9 |
3,904
|
Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Aug 2023 |
1,590 |
96,948
(0%)
|
0%
|
|
0
|
Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Sale of securities on an exchange or to another person at price $ 44.49 per share. |
23 Aug 2023 |
396 |
96,552
(0%)
|
0%
|
44.5 |
17,618
|
Common Stock |
Alessandro Maselli
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 44.51 per share. |
23 Aug 2023 |
1,970 |
88,105
(0%)
|
0%
|
44.5 |
87,685
|
Common Stock |
Alessandro Maselli
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Aug 2023 |
3,974 |
90,075
(0%)
|
0%
|
|
0
|
Common Stock |
Alessandro Maselli
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 45.15 per share. |
23 Aug 2023 |
101 |
88,004
(0%)
|
0%
|
45.1 |
4,560
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 44.57 per share. |
23 Aug 2023 |
269 |
29,932
(0%)
|
0%
|
44.6 |
11,989
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Aug 2023 |
1,081 |
30,201
(0%)
|
0%
|
|
0
|
Common Stock |
Ricardo Pravda
|
Chief Transformation Officer |
Sale of securities on an exchange or to another person at price $ 44.47 per share. |
23 Aug 2023 |
379 |
30,224
(0%)
|
0%
|
44.5 |
16,854
|
Common Stock |
Ricardo Pravda
|
Chief Transformation Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Aug 2023 |
1,081 |
30,603
(0%)
|
0%
|
|
0
|
Common Stock |
Ricky Hopson
|
Pres. Clinical Dev Supply Div |
Sale of securities on an exchange or to another person at price $ 44.56 per share. |
23 Aug 2023 |
276 |
22,040
(0%)
|
0%
|
44.6 |
12,299
|
Common Stock |
Ricky Hopson
|
Pres. Clinical Dev Supply Div |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Aug 2023 |
789 |
21,836
(0%)
|
0%
|
|
0
|
Common Stock |
Lorenzo Carletti
|
SVP Global Ops Ph & Cons Hlth |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Aug 2023 |
457 |
8,962
(0%)
|
0%
|
|
0
|
Common Stock |
Lorenzo Carletti
|
SVP Global Ops Ph & Cons Hlth |
Sale of securities on an exchange or to another person at price $ 44.71 per share. |
23 Aug 2023 |
216 |
8,746
(0%)
|
0%
|
44.7 |
9,657
|
Common Stock |
Thomas W. Hawkeswood
|
Pres. Pharma Prod Delivery Div |
Sale of securities on an exchange or to another person at price $ 44.72 per share. |
23 Aug 2023 |
147 |
7,533
(0%)
|
0%
|
44.7 |
6,574
|
Common Stock |
Thomas W. Hawkeswood
|
Pres. Pharma Prod Delivery Div |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Aug 2023 |
268 |
7,680
(0%)
|
0%
|
|
0
|
Common Stock |
Charles Lickfold
|
SVP, CIO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Aug 2023 |
637 |
11,529
(0%)
|
0%
|
|
0
|
Common Stock |
Charles Lickfold
|
SVP, CIO |
Sale of securities on an exchange or to another person at price $ 44.72 per share. |
23 Aug 2023 |
190 |
11,339
(0%)
|
0%
|
44.7 |
8,497
|
Common Stock |
Gennadios Aristippos
|
Group Pres. Pharma & Consumer |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
396 |
95,358
(0%)
|
0%
|
|
-
|
Common Stock |
Maselli Alessandro
|
Director, President & CEO |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
3,974 |
84,030
(0%)
|
0%
|
|
0
|
Common Stock |
Hawkeswood Thomas W.
|
Pres. Pharma Prod Delivery Div |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
268 |
7,265
(0%)
|
0%
|
|
0
|
Common Stock |
Carletti Lorenzo
|
SVP Global Ops Ph & Cons Hlth |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
457 |
8,289
(0%)
|
0%
|
|
0
|
Common Stock |
Alessandro Maselli
|
Director, President & CEO |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
2,071 |
86,101
(0%)
|
0%
|
|
-
|
Common Stock |
W. Thomas Hawkeswood
|
Pres. Pharma Prod Delivery Div |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
147 |
7,412
(0%)
|
0%
|
|
-
|
Common Stock |
Arnold Jonathan
|
SVP, CCO & Div. Head BioP Del. |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
1,590 |
55,809
(0%)
|
0%
|
|
0
|
Common Stock |
Gunther Scott
|
SVP, Quality & Reg. Affairs |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
269 |
29,120
(0%)
|
0%
|
|
-
|
Common Stock |
Hopson Ricky
|
Pres. Clinical Dev Supply Div |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
789 |
21,251
(0%)
|
0%
|
|
0
|
Common Stock |
J. Michael Grippo
|
SVP, Strategy & Corp. Dev. |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
1,114 |
23,335
(0%)
|
0%
|
|
0
|
Common Stock |
Charles Lickfold
|
SVP, CIO |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
637 |
10,702
(0%)
|
0%
|
|
0
|
Common Stock |
Steven L. Fasman
|
EVP & Chief Admin Officer |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
817 |
72,380
(0%)
|
0%
|
|
-
|
Common Stock |
Gunther Scott
|
SVP, Quality & Reg. Affairs |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
1,081 |
28,851
(0%)
|
0%
|
|
0
|
Common Stock |
Josephine Anne Hunt Patricia
|
Pres. Consumer Health Div |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
106 |
11,106
(0%)
|
0%
|
|
-
|
Common Stock |
Jonathan Arnold
|
SVP, CCO & Div. Head BioP Del. |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
87 |
55,896
(0%)
|
0%
|
|
-
|
Common Stock |
Gennadios Aristippos
|
Group Pres. Pharma & Consumer |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
1,590 |
94,962
(0%)
|
0%
|
|
0
|
Common Stock |
Carletti Lorenzo
|
SVP Global Ops Ph & Cons Hlth |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
216 |
8,505
(0%)
|
0%
|
|
-
|
Common Stock |
Josephine Anne Hunt Patricia
|
Pres. Consumer Health Div |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
289 |
11,000
(0%)
|
0%
|
|
0
|
Common Stock |
Pravda Ricardo
|
Chief Transformation Officer |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
379 |
29,522
(0%)
|
0%
|
|
-
|
Common Stock |
Ricardo Pravda
|
Chief Transformation Officer |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
1,081 |
29,143
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Grippo J.
|
SVP, Strategy & Corp. Dev. |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
390 |
23,725
(0%)
|
0%
|
|
-
|
Common Stock |
Lickfold Charles
|
SVP, CIO |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
190 |
10,892
(0%)
|
0%
|
|
-
|
Common Stock |
L. Fasman Steven
|
EVP & Chief Admin Officer |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
2,226 |
71,563
(0%)
|
0%
|
|
0
|
Common Stock |
Ricky Hopson
|
Pres. Clinical Dev Supply Div |
Other type of transaction at price $ 0.00 per share. |
23 Aug 2023 |
276 |
21,527
(0%)
|
0%
|
|
-
|
Common Stock |
Steven L. Fasman
|
EVP & Chief Admin Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
11,885 |
72,101
(0%)
|
0%
|
|
0
|
Common Stock |
Steven L. Fasman
|
EVP & Chief Admin Officer |
Sale of securities on an exchange or to another person at price $ 47.76 per share. |
01 Aug 2023 |
524 |
60,216
(0%)
|
0%
|
47.8 |
25,026
|
Common Stock |
Steven L. Fasman
|
EVP & Chief Admin Officer |
Sale of securities on an exchange or to another person at price $ 46.72 per share. |
01 Aug 2023 |
1,113 |
60,740
(0%)
|
0%
|
46.7 |
51,999
|
Common Stock |
Steven L. Fasman
|
EVP & Chief Admin Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
26,473 |
26,473
|
-
|
|
-
|
Options to purchase Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Sale of securities on an exchange or to another person at price $ 46.63 per share. |
01 Aug 2023 |
35 |
17,757
(0%)
|
0%
|
46.6 |
1,632
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Sale of securities on an exchange or to another person at price $ 47.88 per share. |
01 Aug 2023 |
241 |
17,516
(0%)
|
0%
|
47.9 |
11,539
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
6,209 |
23,725
(0%)
|
0%
|
|
0
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
13,830 |
13,830
|
-
|
|
-
|
Options to purchase Common Stock |
Patricia Josephine Anne Hunt
|
Pres. Consumer Health Div |
Sale of securities on an exchange or to another person at price $ 47.95 per share. |
01 Aug 2023 |
161 |
9,154
(0%)
|
0%
|
48.0 |
7,720
|
Common Stock |
Patricia Josephine Anne Hunt
|
Pres. Consumer Health Div |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
1,952 |
11,106
(0%)
|
0%
|
|
0
|
Common Stock |
Patricia Josephine Anne Hunt
|
Pres. Consumer Health Div |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
4,347 |
4,347
|
-
|
|
-
|
Options to purchase Common Stock |
Jonathan Arnold
|
SVP, CCO & Div. Head BioP Del. |
Sale of securities on an exchange or to another person at price $ 47.81 per share. |
01 Aug 2023 |
62 |
55,896
(0%)
|
0%
|
47.8 |
2,964
|
Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
19,756 |
19,756
|
-
|
|
-
|
Options to purchase Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Sale of securities on an exchange or to another person at price $ 46.57 per share. |
01 Aug 2023 |
61 |
86,708
(0%)
|
0%
|
46.6 |
2,841
|
Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Sale of securities on an exchange or to another person at price $ 47.87 per share. |
01 Aug 2023 |
220 |
86,488
(0%)
|
0%
|
47.9 |
10,531
|
Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
8,870 |
95,358
(0%)
|
0%
|
|
0
|
Common Stock |
Alessandro Maselli
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 46.71 per share. |
01 Aug 2023 |
879 |
86,707
(0%)
|
0%
|
46.7 |
41,058
|
Common Stock |
Alessandro Maselli
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 47.75 per share. |
01 Aug 2023 |
606 |
86,101
(0%)
|
0%
|
47.8 |
28,937
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
11,854 |
11,854
|
-
|
|
-
|
Options to purchase Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 47.90 per share. |
01 Aug 2023 |
190 |
23,798
(0%)
|
0%
|
47.9 |
9,101
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
5,322 |
29,120
(0%)
|
0%
|
|
0
|
Common Stock |
Karen Murphy Santiago
|
VP & Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
5,216 |
5,216
|
-
|
|
-
|
Options to purchase Common Stock |
Karen Murphy Santiago
|
VP & Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
2,342 |
4,763
(0%)
|
0%
|
|
0
|
Common Stock |
Ricardo Pravda
|
Chief Transformation Officer |
Sale of securities on an exchange or to another person at price $ 46.51 per share. |
01 Aug 2023 |
47 |
19,961
(0%)
|
0%
|
46.5 |
2,186
|
Common Stock |
Ricardo Pravda
|
Chief Transformation Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
9,783 |
29,522
(0%)
|
0%
|
|
0
|
Common Stock |
Ricardo Pravda
|
Chief Transformation Officer |
Sale of securities on an exchange or to another person at price $ 47.78 per share. |
01 Aug 2023 |
222 |
19,739
(0%)
|
0%
|
47.8 |
10,607
|
Common Stock |
Ricky Hopson
|
Pres. Clinical Dev Supply Div |
Sale of securities on an exchange or to another person at price $ 47.86 per share. |
01 Aug 2023 |
195 |
16,257
(0%)
|
0%
|
47.9 |
9,333
|
Common Stock |
Ricky Hopson
|
Pres. Clinical Dev Supply Div |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
10,669 |
10,669
|
-
|
|
-
|
Options to purchase Common Stock |
Ricky Hopson
|
Pres. Clinical Dev Supply Div |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
4,790 |
21,047
(0%)
|
0%
|
|
0
|
Common Stock |
Lorenzo Carletti
|
SVP Global Ops Ph & Cons Hlth |
Sale of securities on an exchange or to another person at price $ 47.77 per share. |
01 Aug 2023 |
383 |
4,602
(0%)
|
0%
|
47.8 |
18,296
|
Common Stock |
Lorenzo Carletti
|
SVP Global Ops Ph & Cons Hlth |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
3,903 |
8,505
(0%)
|
0%
|
|
0
|
Common Stock |
Lorenzo Carletti
|
SVP Global Ops Ph & Cons Hlth |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
8,693 |
8,693
|
-
|
|
-
|
Options to purchase Common Stock |
Thomas W. Hawkeswood
|
Pres. Pharma Prod Delivery Div |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
2,306 |
7,412
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas W. Hawkeswood
|
Pres. Pharma Prod Delivery Div |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
5,137 |
5,137
|
-
|
|
-
|
Options to purchase Common Stock |
Thomas W. Hawkeswood
|
Pres. Pharma Prod Delivery Div |
Sale of securities on an exchange or to another person at price $ 47.97 per share. |
01 Aug 2023 |
258 |
5,106
(0%)
|
0%
|
48.0 |
12,376
|
Common Stock |
Charles Lickfold
|
SVP, CIO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
5,322 |
10,892
(0%)
|
0%
|
|
0
|
Common Stock |
Charles Lickfold
|
SVP, CIO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
11,854 |
11,854
|
-
|
|
-
|
Options to purchase Common Stock |
Charles Lickfold
|
SVP, CIO |
Sale of securities on an exchange or to another person at price $ 47.90 per share. |
01 Aug 2023 |
135 |
5,570
(0%)
|
0%
|
47.9 |
6,467
|
Common Stock |
Joseph Ferraro A.
|
SVP, General Counsel, CCO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
5,145 |
5,145
(0%)
|
0%
|
|
0
|
Common Stock |
Ferraro Joseph A.
|
SVP, General Counsel, CCO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
11,459 |
11,459
|
-
|
|
-
|
Options to purchase Common Stock |
Alessandro Maselli
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2023 |
103,360 |
103,360
|
-
|
|
-
|
Options to purchase Common Stock |
Alessandro Maselli
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2023 |
46,396 |
87,586
(0%)
|
0%
|
|
0
|
Common Stock |
Matti Masanovich
|
SVP, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jul 2023 |
81,082 |
81,082
|
-
|
|
-
|
Options to purchase Common Stock |
Matti Masanovich
|
SVP, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jul 2023 |
36,864 |
36,864
(0%)
|
0%
|
|
0
|
Common Stock |
J. Martin Carroll
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2023 |
555 |
21,078
(0%)
|
0%
|
|
0
|
Common Stock |
Manja Boerman
|
Pres. BioModalities Division |
Sale of securities on an exchange or to another person at price $ 49.86 per share. |
01 May 2023 |
1,446 |
14,414
(0%)
|
0%
|
49.9 |
72,098
|
Common Stock |
Mario Gargiulo
|
SVP, Ops, Biologics Europe |
Sale of securities on an exchange or to another person at price $ 49.86 per share. |
01 May 2023 |
678 |
5,676
(0%)
|
0%
|
49.9 |
33,805
|
Common Stock |
Ricky Hopson
|
Pres. Clinical Dev Supply Div |
Sale of securities on an exchange or to another person at price $ 49.36 per share. |
23 Jan 2023 |
643 |
16,452
(0%)
|
0%
|
49.4 |
31,738
|
Common Stock |
Manja Boerman
|
Pres. BioModalities Division |
Sale of securities on an exchange or to another person at price $ 51.70 per share. |
05 Dec 2022 |
780 |
15,860
(0%)
|
0%
|
51.7 |
40,326
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Sale of securities on an exchange or to another person at price $ 65.83 per share. |
31 Oct 2022 |
2,451 |
17,792
(0%)
|
0%
|
65.8 |
161,349
|
Common Stock |
Donald E. Morel
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2022 |
4,149 |
58,462
(0%)
|
0%
|
|
0
|
Common Stock |
Jack L. Stahl
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2022 |
4,149 |
36,328
(0%)
|
0%
|
|
0
|
Common Stock |
Gregory T. Lucier
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2022 |
4,149 |
25,258
(0%)
|
0%
|
|
0
|
Common Stock |
John J. Greisch
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2022 |
4,149 |
16,880
(0%)
|
0%
|
|
0
|
Common Stock |
Rolf A. Classon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2022 |
4,149 |
36,328
(0%)
|
0%
|
|
0
|
Common Stock |
Madhu Balachandran
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2022 |
4,149 |
20,448
(0%)
|
0%
|
|
0
|
Common Stock |
Rosemary A. Crane
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2022 |
4,149 |
16,880
(0%)
|
0%
|
|
0
|
Common Stock |
Karen A. Flynn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2022 |
4,149 |
17,346
(0%)
|
0%
|
|
0
|
Common Stock |
J. Martin Carroll
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2022 |
4,149 |
20,523
(0%)
|
0%
|
|
0
|
Common Stock |
Christa Kreuzburg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2022 |
4,149 |
13,479
(0%)
|
0%
|
|
0
|
Common Stock |
Christa Kreuzburg
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.27 per share. |
27 Oct 2022 |
421 |
13,058
(0%)
|
0%
|
66.3 |
27,900
|
Common Stock |
Peter Zippelius
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2022 |
4,149 |
11,979
(0%)
|
0%
|
|
0
|
Common Stock |
Michael J. Barber
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Oct 2022 |
4,149 |
6,396
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas W. Hawkeswood
|
Pres. Pharma Prod Delivery Div |
Sale of securities on an exchange or to another person at price $ 77.46 per share. |
10 Oct 2022 |
930 |
5,364
(0%)
|
0%
|
77.5 |
72,038
|
Common Stock |
Karen Murphy Santiago
|
VP & Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Sep 2022 |
740 |
740
(0%)
|
0%
|
|
0
|
Common Stock |
Karen Murphy Santiago
|
VP & Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Sep 2022 |
3,030 |
3,030
|
-
|
|
-
|
Options to purchase Common Stock |
Karen Murphy Santiago
|
VP & Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Sep 2022 |
1,681 |
2,421
(0%)
|
0%
|
|
0
|
Common Stock |
Karen A. Flynn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Sep 2022 |
245 |
13,197
(0%)
|
0%
|
|
0
|
Common Stock |
Ricky Hopson
|
Pres. Clinical Dev Supply Div |
Sale of securities on an exchange or to another person at price $ 89.59 per share. |
31 Aug 2022 |
2,216 |
17,095
(0%)
|
0%
|
89.6 |
198,531
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 104.07 per share. |
26 Aug 2022 |
1,639 |
23,988
(0%)
|
0%
|
104.1 |
170,571
|
Common Stock |
Michael A. Riley
|
Pres. Bio Product Delivery Div |
Sale of securities on an exchange or to another person at price $ 104.07 per share. |
26 Aug 2022 |
2,491 |
6,592
(0%)
|
0%
|
104.1 |
259,238
|
Common Stock |
Steven L. Fasman
|
EVP & Chief Admin Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
10,155 |
66,664
(0%)
|
0%
|
|
0
|
Common Stock |
Steven L. Fasman
|
EVP & Chief Admin Officer |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
4,811 |
61,853
(0%)
|
0%
|
103.0 |
495,725
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
4,890 |
21,913
(0%)
|
0%
|
|
0
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
1,670 |
20,243
(0%)
|
0%
|
103.0 |
172,077
|
Common Stock |
John R. Chiminski
|
Director, Executive Chair |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
38,934 |
229,888
(0%)
|
0%
|
103.0 |
4,011,759
|
Common Stock |
John R. Chiminski
|
Director, Executive Chair |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
99,275 |
268,822
(0%)
|
0%
|
|
0
|
Common Stock |
Patricia Josephine Anne Hunt
|
Pres. Consumer Health Div |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
949 |
9,654
(0%)
|
0%
|
|
0
|
Common Stock |
Patricia Josephine Anne Hunt
|
Pres. Consumer Health Div |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
339 |
9,315
(0%)
|
0%
|
103.0 |
34,931
|
Common Stock |
Jonathan Arnold
|
SVP & Chief Commercial Ofcr |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
384 |
55,958
(0%)
|
0%
|
103.0 |
39,567
|
Common Stock |
Jonathan Arnold
|
SVP & Chief Commercial Ofcr |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
6,621 |
56,342
(0%)
|
0%
|
|
0
|
Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
6,771 |
88,414
(0%)
|
0%
|
|
0
|
Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
1,645 |
86,769
(0%)
|
0%
|
103.0 |
169,501
|
Common Stock |
Alessandro Maselli
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
10,532 |
45,836
(0%)
|
0%
|
|
0
|
Common Stock |
Alessandro Maselli
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
4,646 |
41,190
(0%)
|
0%
|
103.0 |
478,724
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
5,117 |
27,467
(0%)
|
0%
|
|
0
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
1,840 |
25,627
(0%)
|
0%
|
103.0 |
189,594
|
Common Stock |
Kay A Schmidt
|
SVP, Enterprise Functions |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
1,321 |
17,388
(0%)
|
0%
|
103.0 |
136,116
|
Common Stock |
Kay A Schmidt
|
SVP, Enterprise Functions |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
4,139 |
18,709
(0%)
|
0%
|
|
0
|
Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
1,747 |
20,008
(0%)
|
0%
|
103.0 |
180,011
|
Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
5,117 |
21,755
(0%)
|
0%
|
|
0
|
Common Stock |
Manja Boerman
|
Pres. BioModalities Division |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
6,676 |
19,936
(0%)
|
0%
|
|
0
|
Common Stock |
Manja Boerman
|
Pres. BioModalities Division |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
3,296 |
16,640
(0%)
|
0%
|
103.0 |
339,620
|
Common Stock |
Thomas P. Castellano
|
SVP, Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
1,414 |
20,099
(0%)
|
0%
|
103.0 |
145,699
|
Common Stock |
Thomas P. Castellano
|
SVP, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
4,139 |
21,513
(0%)
|
0%
|
|
0
|
Common Stock |
Ricky Hopson
|
Pres. Clinical Dev Supply Div |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
1,517 |
19,311
(0%)
|
0%
|
103.0 |
156,312
|
Common Stock |
Ricky Hopson
|
Pres. Clinical Dev Supply Div |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
3,733 |
20,828
(0%)
|
0%
|
|
0
|
Common Stock |
Mario Gargiulo
|
SVP Global Ops Biologics |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
3,432 |
7,940
(0%)
|
0%
|
|
0
|
Common Stock |
Mario Gargiulo
|
SVP Global Ops Biologics |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
1,586 |
6,354
(0%)
|
0%
|
103.0 |
163,421
|
Common Stock |
Lorenzo Carletti
|
SVP Global Ops Ph & Cons Hlth |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
1,033 |
4,985
(0%)
|
0%
|
103.0 |
106,440
|
Common Stock |
Lorenzo Carletti
|
SVP Global Ops Ph & Cons Hlth |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
2,232 |
6,018
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas W. Hawkeswood
|
Pres. Pharma Prod Delivery Div |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
1,253 |
6,965
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas W. Hawkeswood
|
Pres. Pharma Prod Delivery Div |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
671 |
6,294
(0%)
|
0%
|
103.0 |
69,140
|
Common Stock |
Michael A. Riley
|
Pres. Bio Product Delivery Div |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Aug 2022 |
3,973 |
10,565
(0%)
|
0%
|
|
0
|
Common Stock |
Michael A. Riley
|
Pres. Bio Product Delivery Div |
Sale of securities on an exchange or to another person at price $ 103.04 per share. |
24 Aug 2022 |
1,482 |
9,083
(0%)
|
0%
|
103.0 |
152,705
|
Common Stock |
Steven L. Fasman
|
EVP & Chief Admin Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
12,117 |
12,117
|
-
|
|
-
|
Options to purchase Common Stock |
Steven L. Fasman
|
EVP & Chief Admin Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
2,788 |
56,509
(0%)
|
0%
|
|
0
|
Common Stock |
Steven L. Fasman
|
EVP & Chief Admin Officer |
Sale of securities on an exchange or to another person at price $ 106.90 per share. |
26 Jul 2022 |
2,546 |
53,721
(0%)
|
0%
|
106.9 |
272,167
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
5,655 |
5,655
|
-
|
|
-
|
Options to purchase Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Sale of securities on an exchange or to another person at price $ 106.90 per share. |
26 Jul 2022 |
409 |
16,110
(0%)
|
0%
|
106.9 |
43,722
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
1,301 |
17,411
(0%)
|
0%
|
|
0
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Sale of securities on an exchange or to another person at price $ 107.67 per share. |
26 Jul 2022 |
388 |
17,023
(0%)
|
0%
|
107.7 |
41,776
|
Common Stock |
John R. Chiminski
|
Director, Executive Chair |
Sale of securities on an exchange or to another person at price $ 106.90 per share. |
26 Jul 2022 |
9,691 |
132,382
(0%)
|
0%
|
106.9 |
1,035,968
|
Common Stock |
John R. Chiminski
|
Director, Executive Chair |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
37,165 |
169,547
(0%)
|
0%
|
|
0
|
Common Stock |
Jonathan Arnold
|
SVP & Chief Commercial Ofcr |
Sale of securities on an exchange or to another person at price $ 106.90 per share. |
26 Jul 2022 |
94 |
48,698
(0%)
|
0%
|
106.9 |
10,049
|
Common Stock |
Jonathan Arnold
|
SVP & Chief Commercial Ofcr |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
1,023 |
49,721
(0%)
|
0%
|
|
0
|
Common Stock |
Jonathan Arnold
|
SVP & Chief Commercial Ofcr |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
4,443 |
4,443
|
-
|
|
-
|
Options to purchase Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
8,078 |
8,078
|
-
|
|
-
|
Options to purchase Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Sale of securities on an exchange or to another person at price $ 106.90 per share. |
26 Jul 2022 |
403 |
79,784
(0%)
|
0%
|
106.9 |
43,081
|
Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
1,859 |
81,643
(0%)
|
0%
|
|
0
|
Common Stock |
Alessandro Maselli
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 106.90 per share. |
26 Jul 2022 |
816 |
25,083
(0%)
|
0%
|
106.9 |
87,230
|
Common Stock |
Alessandro Maselli
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
10,221 |
35,304
(0%)
|
0%
|
|
0
|
Common Stock |
Alessandro Maselli
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
44,427 |
44,427
|
-
|
|
-
|
Options to purchase Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 106.90 per share. |
26 Jul 2022 |
450 |
21,629
(0%)
|
0%
|
106.9 |
48,105
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
4,847 |
4,847
|
-
|
|
-
|
Options to purchase Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 107.67 per share. |
26 Jul 2022 |
394 |
22,350
(0%)
|
0%
|
107.7 |
42,422
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
1,115 |
22,744
(0%)
|
0%
|
|
0
|
Common Stock |
Kay A Schmidt
|
SVP, Enterprise Functions |
Sale of securities on an exchange or to another person at price $ 106.90 per share. |
26 Jul 2022 |
323 |
13,455
(0%)
|
0%
|
106.9 |
34,529
|
Common Stock |
Kay A Schmidt
|
SVP, Enterprise Functions |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
1,115 |
14,570
(0%)
|
0%
|
|
0
|
Common Stock |
Kay A Schmidt
|
SVP, Enterprise Functions |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
4,847 |
4,847
|
-
|
|
-
|
Options to purchase Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
1,301 |
16,638
(0%)
|
0%
|
|
0
|
Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
5,655 |
5,655
|
-
|
|
-
|
Options to purchase Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Sale of securities on an exchange or to another person at price $ 106.90 per share. |
26 Jul 2022 |
427 |
15,337
(0%)
|
0%
|
106.9 |
45,646
|
Common Stock |
Thomas P. Castellano
|
SVP, Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 106.90 per share. |
26 Jul 2022 |
347 |
15,051
(0%)
|
0%
|
106.9 |
37,094
|
Common Stock |
Thomas P. Castellano
|
SVP, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
10,097 |
10,097
|
-
|
|
-
|
Options to purchase Common Stock |
Thomas P. Castellano
|
SVP, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
2,323 |
17,374
(0%)
|
0%
|
|
0
|
Common Stock |
Ricky Hopson
|
Pres, Clinical Dev & Supply |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
651 |
17,686
(0%)
|
0%
|
|
0
|
Common Stock |
Ricky Hopson
|
Pres, Clinical Dev & Supply |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
2,828 |
2,828
|
-
|
|
-
|
Options to purchase Common Stock |
Ricky Hopson
|
Pres, Clinical Dev & Supply |
Sale of securities on an exchange or to another person at price $ 107.67 per share. |
26 Jul 2022 |
591 |
17,095
(0%)
|
0%
|
107.7 |
63,633
|
Common Stock |
Ricky Hopson
|
Pres, Clinical Dev & Supply |
Sale of securities on an exchange or to another person at price $ 106.90 per share. |
26 Jul 2022 |
312 |
17,035
(0%)
|
0%
|
106.9 |
33,353
|
Common Stock |
Mario Gargiulo
|
SVP Global Ops Biologics |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
837 |
4,508
(0%)
|
0%
|
|
0
|
Common Stock |
Mario Gargiulo
|
SVP Global Ops Biologics |
Sale of securities on an exchange or to another person at price $ 106.90 per share. |
26 Jul 2022 |
969 |
3,671
(0%)
|
0%
|
106.9 |
103,586
|
Common Stock |
Mario Gargiulo
|
SVP Global Ops Biologics |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
3,635 |
3,635
|
-
|
|
-
|
Options to purchase Common Stock |
Lorenzo Carletti
|
SVP Global Ops Ph & Cons Hlth |
Sale of securities on an exchange or to another person at price $ 106.90 per share. |
26 Jul 2022 |
631 |
2,949
(0%)
|
0%
|
106.9 |
67,454
|
Common Stock |
Lorenzo Carletti
|
SVP Global Ops Ph & Cons Hlth |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
3,635 |
3,635
|
-
|
|
-
|
Options to purchase Common Stock |
Lorenzo Carletti
|
SVP Global Ops Ph & Cons Hlth |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2022 |
837 |
3,786
(0%)
|
0%
|
|
0
|
Common Stock |
Jonathan Arnold
|
SVP & Chief Commercial Ofcr |
Grant, award, or other acquisition of securities at price $ 107.02 per share. |
01 Jul 2022 |
2,804 |
48,792
(0%)
|
0%
|
107.0 |
300,084
|
Common Stock |
Aristippos Gennadios
|
Group Pres. Pharma & Consumer |
Grant, award, or other acquisition of securities at price $ 107.02 per share. |
01 Jul 2022 |
18,689 |
80,187
(0%)
|
0%
|
107.0 |
2,000,097
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 106.77 per share. |
10 Jun 2022 |
3,049 |
58,129
(0%)
|
0%
|
106.8 |
325,542
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 107.54 per share. |
10 Jun 2022 |
1,951 |
56,178
(0%)
|
0%
|
107.5 |
209,811
|
Common Stock |
Mario Gargiulo
|
SVP Global Ops Large Molecule |
Sale of securities on an exchange or to another person at price $ 106.59 per share. |
10 Jun 2022 |
118 |
4,640
(0%)
|
0%
|
106.6 |
12,578
|
Common Stock |
Peter Zippelius
|
Director |
Sale of securities on an exchange or to another person at price $ 102.65 per share. |
06 Feb 2022 |
487,092 |
4,330,462
(2%)
|
0%
|
102.7 |
49,999,994
|
Common Stock |
Ricky Hopson
|
VP, Chief Accounting Officer |
Sale of securities on an exchange or to another person at price $ 103.39 per share. |
31 Jan 2022 |
2,325 |
17,073
(0%)
|
0%
|
103.4 |
240,382
|
Common Stock |
Ricci S Whitlow
|
President, CSS |
Sale of securities on an exchange or to another person at price $ 102.37 per share. |
21 Jan 2022 |
184 |
2,923
(0%)
|
0%
|
102.4 |
18,836
|
Common Stock |
Karen A. Flynn
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 116.64 per share. |
10 Jan 2022 |
2,472 |
33,223
(0%)
|
0%
|
116.6 |
288,334
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2022 |
4,017 |
61,178
(0%)
|
0%
|
|
0
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2022 |
4,017 |
16,519
(0%)
|
0%
|
|
0
|
Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2022 |
4,017 |
45,988
(0%)
|
0%
|
|
0
|
Common Stock |
Aristippos Gennadios
|
President Softgel & Oral Tech |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2022 |
4,017 |
61,498
(0%)
|
0%
|
|
0
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2022 |
4,017 |
22,079
(0%)
|
0%
|
|
0
|
Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2022 |
4,017 |
15,764
(0%)
|
0%
|
|
0
|
Common Stock |
J. Martin Carroll
|
Director |
Other type of transaction at price $ 134.12 per share. |
29 Nov 2021 |
3,136 |
11,663
(0%)
|
0%
|
134.1 |
420,600
|
Common Stock |
J. Martin Carroll
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
29 Nov 2021 |
3,136 |
16,374
(0%)
|
0%
|
|
0
|
Common Stock |
J. Martin Carroll
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
29 Nov 2021 |
3,136 |
3,136
(0%)
|
0%
|
|
0
|
Common Stock |
J. Martin Carroll
|
Director |
Other type of transaction at price $ 134.12 per share. |
29 Nov 2021 |
3,136 |
0
(0%)
|
0%
|
134.1 |
420,600
|
Common Stock |
Gregory T. Lucier
|
Director |
Sale of securities on an exchange or to another person at price $ 127.76 per share. |
23 Nov 2021 |
2,400 |
0
(0%)
|
0%
|
127.8 |
306,624
|
Common Stock |
Gregory T. Lucier
|
Director |
Sale of securities on an exchange or to another person at price $ 126.98 per share. |
23 Nov 2021 |
2,668 |
2,400
(0%)
|
0%
|
127.0 |
338,783
|
Common Stock |
Peter Zippelius
|
Director |
|
18 Nov 2021 |
384,777 |
0
|
-
|
|
-
|
Series A Convertible Preferred Stock |
Peter Zippelius
|
Director |
|
18 Nov 2021 |
7,822,946 |
7,822,946
(5%)
|
5%
|
49.5 |
387,555,785
|
Common Stock |
Peter Zippelius
|
Director |
Sale of securities on an exchange or to another person at price $ 129.30 per share. |
18 Nov 2021 |
3,000,000 |
4,822,946
(3%)
|
1%
|
129.3 |
387,900,000
|
Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.23 per share. |
01 Nov 2021 |
1,039 |
48,085
(0%)
|
0%
|
42.2 |
43,877
|
Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Nov 2021 |
2,158 |
4,318
|
-
|
|
-
|
Options to purchase Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Nov 2021 |
2,400 |
2,745
|
-
|
|
-
|
Options to purchase Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Nov 2021 |
1,039 |
1,042
|
-
|
|
-
|
Options to purchase Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Nov 2021 |
1,962 |
0
|
-
|
|
-
|
Options to purchase Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Sale of securities on an exchange or to another person at price $ 140.02 per share. |
01 Nov 2021 |
10,672 |
41,971
(0%)
|
0%
|
140.0 |
1,494,293
|
Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.94 per share. |
01 Nov 2021 |
2,158 |
52,643
(0%)
|
0%
|
54.9 |
118,561
|
Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.88 per share. |
01 Nov 2021 |
2,400 |
50,485
(0%)
|
0%
|
43.9 |
105,312
|
Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.02 per share. |
01 Nov 2021 |
1,962 |
47,046
(0%)
|
0%
|
36.0 |
70,671
|
Common Stock |
Donald E. Morel
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Oct 2021 |
1,402 |
54,313
(0%)
|
0%
|
|
0
|
Common Stock |
Jack L. Stahl
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Oct 2021 |
1,402 |
32,179
(0%)
|
0%
|
|
0
|
Common Stock |
Gregory T. Lucier
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Oct 2021 |
1,402 |
21,109
(0%)
|
0%
|
|
0
|
Common Stock |
John J. Greisch
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Oct 2021 |
1,402 |
12,731
(0%)
|
0%
|
|
0
|
Common Stock |
Rolf A. Classon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Oct 2021 |
1,402 |
32,179
(0%)
|
0%
|
|
0
|
Common Stock |
Madhu Balachandran
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Oct 2021 |
1,402 |
16,299
(0%)
|
0%
|
|
0
|
Common Stock |
Rosemary A. Crane
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Oct 2021 |
1,402 |
12,731
(0%)
|
0%
|
|
0
|
Common Stock |
J. Martin Carroll
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Oct 2021 |
1,402 |
19,510
(0%)
|
0%
|
|
0
|
Common Stock |
Christa Kreuzburg
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.50 per share. |
28 Oct 2021 |
638 |
9,330
(0%)
|
0%
|
135.5 |
86,449
|
Common Stock |
Christa Kreuzburg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Oct 2021 |
1,402 |
9,968
(0%)
|
0%
|
|
0
|
Common Stock |
Peter Zippelius
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Oct 2021 |
1,402 |
7,830
(0%)
|
0%
|
|
0
|
Common Stock |
Michael J. Barber
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Oct 2021 |
1,402 |
2,247
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas P. Castellano
|
SVP, Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 134.00 per share. |
20 Oct 2021 |
2,307 |
15,398
(0%)
|
0%
|
134 |
309,138
|
Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Sale of securities on an exchange or to another person at price $ 129.41 per share. |
14 Oct 2021 |
1,661 |
45,084
(0%)
|
0%
|
129.4 |
214,950
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.02 per share. |
04 Oct 2021 |
4,683 |
79,271
(0%)
|
0%
|
36.0 |
168,682
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Oct 2021 |
2,155 |
6,466
|
-
|
|
-
|
Options to purchase Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Oct 2021 |
6,622 |
6,622
|
-
|
|
-
|
Options to purchase Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Oct 2021 |
3,799 |
3,802
|
-
|
|
-
|
Options to purchase Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Oct 2021 |
4,683 |
0
|
-
|
|
-
|
Options to purchase Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 131.04 per share. |
04 Oct 2021 |
1,800 |
57,133
(0%)
|
0%
|
131.0 |
235,872
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 130.39 per share. |
04 Oct 2021 |
4,192 |
58,933
(0%)
|
0%
|
130.4 |
546,595
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 129.17 per share. |
04 Oct 2021 |
8,209 |
63,125
(0%)
|
0%
|
129.2 |
1,060,357
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 128.56 per share. |
04 Oct 2021 |
20,513 |
71,334
(0%)
|
0%
|
128.6 |
2,637,151
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.10 per share. |
04 Oct 2021 |
2,155 |
91,847
(0%)
|
0%
|
88.1 |
189,856
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.94 per share. |
04 Oct 2021 |
6,622 |
89,692
(0%)
|
0%
|
54.9 |
363,813
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.88 per share. |
04 Oct 2021 |
3,799 |
83,070
(0%)
|
0%
|
43.9 |
166,700
|
Common Stock |
Kay A Schmidt
|
SVP, Technical Operations |
Sale of securities on an exchange or to another person at price $ 131.25 per share. |
04 Oct 2021 |
2,191 |
13,778
(0%)
|
0%
|
131.3 |
287,569
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Sale of securities on an exchange or to another person at price $ 128.00 per share. |
01 Oct 2021 |
200 |
14,357
(0%)
|
0%
|
128 |
25,600
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Sale of securities on an exchange or to another person at price $ 129.05 per share. |
01 Oct 2021 |
100 |
14,257
(0%)
|
0%
|
129.1 |
12,905
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Sale of securities on an exchange or to another person at price $ 131.14 per share. |
01 Oct 2021 |
416 |
13,841
(0%)
|
0%
|
131.1 |
54,554
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Sale of securities on an exchange or to another person at price $ 132.56 per share. |
01 Oct 2021 |
1,339 |
12,502
(0%)
|
0%
|
132.6 |
177,498
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.91 per share. |
01 Oct 2021 |
15,264 |
260,075
(0%)
|
0%
|
34.9 |
532,866
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2021 |
34,635 |
34,638
|
-
|
|
-
|
Options to purchase Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2021 |
15,264 |
0
|
-
|
|
-
|
Options to purchase Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2021 |
25,939 |
0
|
-
|
|
-
|
Options to purchase Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Sale of securities on an exchange or to another person at price $ 132.86 per share. |
01 Oct 2021 |
4,888 |
142,073
(0%)
|
0%
|
132.9 |
649,420
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Sale of securities on an exchange or to another person at price $ 132.18 per share. |
01 Oct 2021 |
64,031 |
146,961
(0%)
|
0%
|
132.2 |
8,463,618
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Sale of securities on an exchange or to another person at price $ 131.21 per share. |
01 Oct 2021 |
26,662 |
210,992
(0%)
|
0%
|
131.2 |
3,498,321
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Sale of securities on an exchange or to another person at price $ 130.39 per share. |
01 Oct 2021 |
21,245 |
237,654
(0%)
|
0%
|
130.4 |
2,770,136
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Sale of securities on an exchange or to another person at price $ 129.22 per share. |
01 Oct 2021 |
12,700 |
258,899
(0%)
|
0%
|
129.2 |
1,641,094
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Sale of securities on an exchange or to another person at price $ 128.10 per share. |
01 Oct 2021 |
18,510 |
271,599
(0%)
|
0%
|
128.1 |
2,371,131
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Sale of securities on an exchange or to another person at price $ 127.34 per share. |
01 Oct 2021 |
4,601 |
290,109
(0%)
|
0%
|
127.3 |
585,891
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.88 per share. |
01 Oct 2021 |
34,635 |
294,710
(0%)
|
0%
|
43.9 |
1,519,784
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.02 per share. |
01 Oct 2021 |
25,939 |
244,811
(0%)
|
0%
|
36.0 |
934,323
|
Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2021 |
2,855 |
3,817
|
-
|
|
-
|
Options to purchase Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2021 |
963 |
3,225
|
-
|
|
-
|
Options to purchase Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Sale of securities on an exchange or to another person at price $ 132.68 per share. |
01 Oct 2021 |
4,906 |
11,747
(0%)
|
0%
|
132.7 |
650,928
|
Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.10 per share. |
01 Oct 2021 |
963 |
16,653
(0%)
|
0%
|
88.1 |
84,840
|
Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.94 per share. |
01 Oct 2021 |
2,855 |
15,690
(0%)
|
0%
|
54.9 |
156,854
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
01 Sep 2021 |
11,000 |
218,872
(0%)
|
0%
|
|
0
|
Common Stock |
Christa Kreuzburg
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 129.85 per share. |
27 Aug 2021 |
199 |
8,566
(0%)
|
0%
|
129.8 |
25,840
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Aug 2021 |
11,566 |
80,699
(0%)
|
0%
|
|
0
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 131.20 per share. |
26 Aug 2021 |
5,650 |
74,588
(0%)
|
0%
|
131.2 |
741,280
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 130.29 per share. |
26 Aug 2021 |
461 |
80,238
(0%)
|
0%
|
130.3 |
60,064
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Sale of securities on an exchange or to another person at price $ 130.29 per share. |
26 Aug 2021 |
128 |
16,127
(0%)
|
0%
|
130.3 |
16,677
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Aug 2021 |
4,984 |
16,255
(0%)
|
0%
|
|
0
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Sale of securities on an exchange or to another person at price $ 131.20 per share. |
26 Aug 2021 |
1,570 |
14,557
(0%)
|
0%
|
131.2 |
205,984
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Sale of securities on an exchange or to another person at price $ 131.12 per share. |
26 Aug 2021 |
40,888 |
229,872
(0%)
|
0%
|
131.1 |
5,361,235
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Sale of securities on an exchange or to another person at price $ 130.41 per share. |
26 Aug 2021 |
3,600 |
270,760
(0%)
|
0%
|
130.4 |
469,476
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Aug 2021 |
105,418 |
274,360
(0%)
|
0%
|
|
0
|
Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Aug 2021 |
7,830 |
47,197
(0%)
|
0%
|
|
0
|
Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Sale of securities on an exchange or to another person at price $ 131.20 per share. |
26 Aug 2021 |
417 |
46,745
(0%)
|
0%
|
131.2 |
54,710
|
Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Sale of securities on an exchange or to another person at price $ 130.29 per share. |
26 Aug 2021 |
35 |
47,162
(0%)
|
0%
|
130.3 |
4,560
|
Common Stock |
Aristippos Gennadios
|
President Softgel & Oral Tech |
Sale of securities on an exchange or to another person at price $ 131.20 per share. |
26 Aug 2021 |
2,091 |
57,481
(0%)
|
0%
|
131.2 |
274,339
|
Common Stock |
Aristippos Gennadios
|
President Softgel & Oral Tech |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Aug 2021 |
8,008 |
59,743
(0%)
|
0%
|
|
0
|
Common Stock |
Aristippos Gennadios
|
President Softgel & Oral Tech |
Sale of securities on an exchange or to another person at price $ 130.29 per share. |
26 Aug 2021 |
171 |
59,572
(0%)
|
0%
|
130.3 |
22,280
|
Common Stock |
Alessandro Maselli
|
President & COO |
Sale of securities on an exchange or to another person at price $ 131.20 per share. |
26 Aug 2021 |
3,460 |
25,899
(0%)
|
0%
|
131.2 |
453,952
|
Common Stock |
Alessandro Maselli
|
President & COO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Aug 2021 |
8,008 |
29,642
(0%)
|
0%
|
|
0
|
Common Stock |
Alessandro Maselli
|
President & COO |
Sale of securities on an exchange or to another person at price $ 130.29 per share. |
26 Aug 2021 |
283 |
29,359
(0%)
|
0%
|
130.3 |
36,872
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Aug 2021 |
6,052 |
22,235
(0%)
|
0%
|
|
0
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 130.29 per share. |
26 Aug 2021 |
173 |
22,062
(0%)
|
0%
|
130.3 |
22,540
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 130.34 per share. |
26 Aug 2021 |
1,878 |
18,062
(0%)
|
0%
|
130.3 |
244,779
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 131.20 per share. |
26 Aug 2021 |
2,122 |
19,940
(0%)
|
0%
|
131.2 |
278,406
|
Common Stock |
Kay A Schmidt
|
SVP, Technical Operations |
Sale of securities on an exchange or to another person at price $ 130.29 per share. |
26 Aug 2021 |
63 |
16,731
(0%)
|
0%
|
130.3 |
8,208
|
Common Stock |
Kay A Schmidt
|
SVP, Technical Operations |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Aug 2021 |
2,590 |
16,794
(0%)
|
0%
|
|
0
|
Common Stock |
Kay A Schmidt
|
SVP, Technical Operations |
Sale of securities on an exchange or to another person at price $ 131.20 per share. |
26 Aug 2021 |
762 |
15,969
(0%)
|
0%
|
131.2 |
99,974
|
Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Sale of securities on an exchange or to another person at price $ 130.28 per share. |
26 Aug 2021 |
53 |
13,474
(0%)
|
0%
|
130.3 |
6,905
|
Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Sale of securities on an exchange or to another person at price $ 131.20 per share. |
26 Aug 2021 |
639 |
12,835
(0%)
|
0%
|
131.2 |
83,837
|
Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Aug 2021 |
2,030 |
13,527
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas P. Castellano
|
SVP, Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 131.20 per share. |
26 Aug 2021 |
1,935 |
17,705
(0%)
|
0%
|
131.2 |
253,872
|
Common Stock |
Thomas P. Castellano
|
SVP, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Aug 2021 |
4,273 |
19,798
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas P. Castellano
|
SVP, Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 130.29 per share. |
26 Aug 2021 |
158 |
19,640
(0%)
|
0%
|
130.3 |
20,586
|
Common Stock |
Ricky Hopson
|
VP, Chief Accounting Officer |
Sale of securities on an exchange or to another person at price $ 130.29 per share. |
26 Aug 2021 |
111 |
20,758
(0%)
|
0%
|
130.3 |
14,462
|
Common Stock |
Ricky Hopson
|
VP, Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Aug 2021 |
4,317 |
20,869
(0%)
|
0%
|
|
0
|
Common Stock |
Ricky Hopson
|
VP, Chief Accounting Officer |
Sale of securities on an exchange or to another person at price $ 131.20 per share. |
26 Aug 2021 |
1,360 |
19,398
(0%)
|
0%
|
131.2 |
178,432
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 113.05 per share. |
26 Jul 2021 |
1,549 |
67,363
(0%)
|
0%
|
113.0 |
175,114
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
9,158 |
9,158
|
-
|
|
-
|
Options to purchase Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
1,770 |
69,133
(0%)
|
0%
|
|
0
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
974 |
17,579
(0%)
|
0%
|
|
0
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
5,037 |
5,037
|
-
|
|
-
|
Options to purchase Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Sale of securities on an exchange or to another person at price $ 113.05 per share. |
26 Jul 2021 |
451 |
16,605
(0%)
|
0%
|
113.1 |
50,986
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
16,461 |
168,942
(0%)
|
0%
|
|
0
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
85,165 |
85,165
|
-
|
|
-
|
Options to purchase Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Sale of securities on an exchange or to another person at price $ 113.05 per share. |
26 Jul 2021 |
11,137 |
152,481
(0%)
|
0%
|
113.1 |
1,259,038
|
Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
4,579 |
4,579
|
-
|
|
-
|
Options to purchase Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Sale of securities on an exchange or to another person at price $ 113.05 per share. |
26 Jul 2021 |
120 |
38,482
(0%)
|
0%
|
113.1 |
13,566
|
Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
885 |
39,367
(0%)
|
0%
|
|
0
|
Common Stock |
Karen A. Flynn
|
Pres. Biologics & CCO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
5,953 |
5,953
|
-
|
|
-
|
Options to purchase Common Stock |
Karen A. Flynn
|
Pres. Biologics & CCO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
1,151 |
35,695
(0%)
|
0%
|
|
0
|
Common Stock |
Aristippos Gennadios
|
President Softgel & Oral Tech |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
4,579 |
4,579
|
-
|
|
-
|
Options to purchase Common Stock |
Aristippos Gennadios
|
President Softgel & Oral Tech |
Sale of securities on an exchange or to another person at price $ 113.05 per share. |
26 Jul 2021 |
465 |
50,850
(0%)
|
0%
|
113.0 |
52,568
|
Common Stock |
Aristippos Gennadios
|
President Softgel & Oral Tech |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
885 |
51,735
(0%)
|
0%
|
|
0
|
Common Stock |
Alessandro Maselli
|
President & COO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
3,009 |
21,634
(0%)
|
0%
|
|
0
|
Common Stock |
Alessandro Maselli
|
President & COO |
Sale of securities on an exchange or to another person at price $ 113.05 per share. |
26 Jul 2021 |
993 |
18,625
(0%)
|
0%
|
113.1 |
112,259
|
Common Stock |
Alessandro Maselli
|
President & COO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
15,568 |
15,568
|
-
|
|
-
|
Options to purchase Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 113.02 per share. |
26 Jul 2021 |
470 |
15,430
(0%)
|
0%
|
113.0 |
53,119
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
753 |
16,183
(0%)
|
0%
|
|
0
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
3,892 |
3,892
|
-
|
|
-
|
Options to purchase Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 113.05 per share. |
26 Jul 2021 |
609 |
15,900
(0%)
|
0%
|
113.0 |
68,847
|
Common Stock |
Kay A Schmidt
|
SVP, Technical Operations |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
885 |
14,204
(0%)
|
0%
|
|
0
|
Common Stock |
Kay A Schmidt
|
SVP, Technical Operations |
Sale of securities on an exchange or to another person at price $ 113.05 per share. |
26 Jul 2021 |
547 |
13,319
(0%)
|
0%
|
113.0 |
61,838
|
Common Stock |
Kay A Schmidt
|
SVP, Technical Operations |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
4,579 |
4,579
|
-
|
|
-
|
Options to purchase Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
885 |
11,497
(0%)
|
0%
|
|
0
|
Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
4,579 |
4,579
|
-
|
|
-
|
Options to purchase Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Sale of securities on an exchange or to another person at price $ 113.05 per share. |
26 Jul 2021 |
458 |
10,612
(0%)
|
0%
|
113.1 |
51,777
|
Common Stock |
Ricci S Whitlow
|
President, CSS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
2,748 |
2,748
|
-
|
|
-
|
Options to purchase Common Stock |
Ricci S Whitlow
|
President, CSS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
531 |
3,107
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas P. Castellano
|
SVP, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
5,495 |
5,495
|
-
|
|
-
|
Options to purchase Common Stock |
Thomas P. Castellano
|
SVP, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
1,062 |
15,525
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas P. Castellano
|
SVP, Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 113.05 per share. |
26 Jul 2021 |
555 |
14,463
(0%)
|
0%
|
113.1 |
62,743
|
Common Stock |
Ricky Hopson
|
VP, Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
496 |
16,552
(0%)
|
0%
|
|
0
|
Common Stock |
Ricky Hopson
|
VP, Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jul 2021 |
2,565 |
2,565
|
-
|
|
-
|
Options to purchase Common Stock |
Ricky Hopson
|
VP, Chief Accounting Officer |
Sale of securities on an exchange or to another person at price $ 113.05 per share. |
26 Jul 2021 |
360 |
16,056
(0%)
|
0%
|
113.1 |
40,698
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 109.64 per share. |
15 Jul 2021 |
3,313 |
70,099
(0%)
|
0%
|
109.6 |
363,237
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 110.46 per share. |
15 Jul 2021 |
1,187 |
68,912
(0%)
|
0%
|
110.5 |
131,116
|
Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Sale of securities on an exchange or to another person at price $ 110.58 per share. |
23 Jun 2021 |
2,800 |
11,070
(0%)
|
0%
|
110.6 |
309,624
|
Common Stock |
Thomas P. Castellano
|
SVP, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jun 2021 |
2,451 |
15,018
(0%)
|
0%
|
|
0
|
Common Stock |
Ricky Hopson
|
VP, Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jun 2021 |
3,432 |
16,325
(0%)
|
0%
|
|
0
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 May 2021 |
10 |
17,056
(0%)
|
0%
|
|
0
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 May 2021 |
10 |
17,066
(0%)
|
0%
|
|
0
|
Common Stock |
Michael J. Barber
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Apr 2021 |
845 |
845
(0%)
|
0%
|
|
0
|
Common Stock |
Kay A Schmidt
|
SVP, Technical Operations |
Sale of securities on an exchange or to another person at price $ 105.77 per share. |
22 Mar 2021 |
1,400 |
13,866
(0%)
|
0%
|
105.8 |
148,078
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 104.96 per share. |
18 Mar 2021 |
8,732 |
73,307
(0%)
|
0%
|
105.0 |
916,511
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 104.24 per share. |
18 Mar 2021 |
12,915 |
82,039
(0%)
|
0%
|
104.2 |
1,346,260
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.02 per share. |
18 Mar 2021 |
14,049 |
87,356
(0%)
|
0%
|
36.0 |
506,045
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.88 per share. |
18 Mar 2021 |
7,598 |
94,954
(0%)
|
0%
|
43.9 |
333,400
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Mar 2021 |
7,598 |
7,601
|
-
|
|
-
|
Options to purchase Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Mar 2021 |
14,049 |
4,683
|
-
|
|
-
|
Options to purchase Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Mar 2021 |
32,374 |
97,123
|
-
|
|
-
|
Options to purchase Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Mar 2021 |
69,270 |
69,273
|
-
|
|
-
|
Options to purchase Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Mar 2021 |
45,792 |
15,264
|
-
|
|
-
|
Options to purchase Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Mar 2021 |
35,588 |
25,939
|
-
|
|
-
|
Options to purchase Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Mar 2021 |
42,220 |
61,527
|
-
|
|
-
|
Options to purchase Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Sale of securities on an exchange or to another person at price $ 107.07 per share. |
18 Mar 2021 |
800 |
163,618
(0%)
|
0%
|
107.1 |
85,656
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Sale of securities on an exchange or to another person at price $ 106.24 per share. |
18 Mar 2021 |
111,641 |
164,418
(0%)
|
0%
|
106.2 |
11,860,740
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Sale of securities on an exchange or to another person at price $ 105.64 per share. |
18 Mar 2021 |
70,583 |
276,059
(0%)
|
0%
|
105.6 |
7,456,388
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.94 per share. |
18 Mar 2021 |
32,374 |
346,642
(0%)
|
0%
|
54.9 |
1,778,628
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.88 per share. |
18 Mar 2021 |
69,270 |
314,268
(0%)
|
0%
|
43.9 |
3,039,568
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.91 per share. |
18 Mar 2021 |
45,792 |
244,998
(0%)
|
0%
|
34.9 |
1,598,599
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.02 per share. |
18 Mar 2021 |
35,588 |
199,206
(0%)
|
0%
|
36.0 |
1,281,880
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Sale of securities on an exchange or to another person at price $ 105.16 per share. |
18 Mar 2021 |
42,220 |
163,618
(0%)
|
0%
|
105.2 |
4,439,855
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.02 per share. |
18 Mar 2021 |
42,220 |
205,838
(0%)
|
0%
|
36.0 |
1,520,764
|
Common Stock |
Wetteny Joseph
|
SVP & Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.88 per share. |
16 Feb 2021 |
1,076 |
50,899
(0%)
|
0%
|
43.9 |
47,215
|
Common Stock |
Wetteny Joseph
|
SVP & Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Feb 2021 |
3,924 |
11,773
|
-
|
|
-
|
Options to purchase Common Stock |
Wetteny Joseph
|
SVP & Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Feb 2021 |
1,076 |
17,631
|
-
|
|
-
|
Options to purchase Common Stock |
Wetteny Joseph
|
SVP & Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 127.00 per share. |
16 Feb 2021 |
1,000 |
49,823
(0%)
|
0%
|
127 |
127,000
|
Common Stock |
Wetteny Joseph
|
SVP & Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 126.13 per share. |
16 Feb 2021 |
1,001 |
50,823
(0%)
|
0%
|
126.1 |
126,256
|
Common Stock |
Wetteny Joseph
|
SVP & Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 123.73 per share. |
16 Feb 2021 |
1,200 |
51,824
(0%)
|
0%
|
123.7 |
148,476
|
Common Stock |
Wetteny Joseph
|
SVP & Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 122.82 per share. |
16 Feb 2021 |
1,799 |
53,024
(0%)
|
0%
|
122.8 |
220,953
|
Common Stock |
Wetteny Joseph
|
SVP & Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.94 per share. |
16 Feb 2021 |
3,924 |
54,823
(0%)
|
0%
|
54.9 |
215,585
|
Common Stock |
Wetteny Joseph
|
SVP & Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 113.73 per share. |
08 Feb 2021 |
4,604 |
49,823
(0%)
|
0%
|
113.7 |
523,613
|
Common Stock |
Ricci S Whitlow
|
President, CSS |
Sale of securities on an exchange or to another person at price $ 118.85 per share. |
21 Jan 2021 |
692 |
2,576
(0%)
|
0%
|
118.8 |
82,244
|
Common Stock |
Karen A. Flynn
|
Pres. Biologics & CCO |
Sale of securities on an exchange or to another person at price $ 112.14 per share. |
11 Jan 2021 |
1,378 |
35,644
(0%)
|
0%
|
112.1 |
154,529
|
Common Stock |
Karen A. Flynn
|
Pres. Biologics & CCO |
Sale of securities on an exchange or to another person at price $ 112.50 per share. |
11 Jan 2021 |
1,100 |
34,544
(0%)
|
0%
|
112.5 |
123,750
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 104.79 per share. |
06 Jan 2021 |
61 |
16,509
(0%)
|
0%
|
104.8 |
6,392
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 104.42 per share. |
04 Jan 2021 |
189 |
73,307
(0%)
|
0%
|
104.4 |
19,735
|
Common Stock |
Wetteny Joseph
|
SVP & Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 104.42 per share. |
04 Jan 2021 |
172 |
54,427
(0%)
|
0%
|
104.4 |
17,960
|
Common Stock |
Michael J. Grippo
|
SVP, Strategy & Corp. Dev. |
Sale of securities on an exchange or to another person at price $ 104.42 per share. |
04 Jan 2021 |
126 |
17,076
(0%)
|
0%
|
104.4 |
13,157
|
Common Stock |
Jonathan Arnold
|
Pres. Oral & Specialty Deliv. |
Sale of securities on an exchange or to another person at price $ 104.44 per share. |
04 Jan 2021 |
16 |
38,602
(0%)
|
0%
|
104.4 |
1,671
|
Common Stock |
Karen A. Flynn
|
Pres. Biologics & CCO |
Sale of securities on an exchange or to another person at price $ 104.42 per share. |
04 Jan 2021 |
99 |
37,022
(0%)
|
0%
|
104.4 |
10,338
|
Common Stock |
Aristippos Gennadios
|
President Softgel & Oral Tech |
Sale of securities on an exchange or to another person at price $ 104.42 per share. |
04 Jan 2021 |
110 |
51,315
(0%)
|
0%
|
104.4 |
11,486
|
Common Stock |
Alessandro Maselli
|
President & COO |
Sale of securities on an exchange or to another person at price $ 104.42 per share. |
04 Jan 2021 |
148 |
19,618
(0%)
|
0%
|
104.4 |
15,454
|
Common Stock |
Scott Gunther
|
SVP, Quality & Reg. Affairs |
Sale of securities on an exchange or to another person at price $ 104.42 per share. |
04 Jan 2021 |
120 |
16,570
(0%)
|
0%
|
104.4 |
12,530
|
Common Stock |
Kay A Schmidt
|
SVP, Technical Operations |
Sale of securities on an exchange or to another person at price $ 104.42 per share. |
04 Jan 2021 |
73 |
15,266
(0%)
|
0%
|
104.4 |
7,623
|
Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Sale of securities on an exchange or to another person at price $ 104.42 per share. |
04 Jan 2021 |
78 |
13,870
(0%)
|
0%
|
104.4 |
8,145
|
Common Stock |
Ricci S Whitlow
|
President, CSS |
Sale of securities on an exchange or to another person at price $ 104.42 per share. |
04 Jan 2021 |
83 |
3,268
(0%)
|
0%
|
104.4 |
8,667
|
Common Stock |
Aristippos Gennadios
|
President Softgel & Oral Tech |
Sale of securities on an exchange or to another person at price $ 102.80 per share. |
21 Dec 2020 |
9,726 |
51,425
(0%)
|
0%
|
102.8 |
999,833
|
Common Stock |
Aristippos Gennadios
|
President Softgel & Oral Tech |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Dec 2020 |
9,726 |
3,243
|
-
|
|
-
|
Options to purchase Common Stock |
Aristippos Gennadios
|
President Softgel & Oral Tech |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Dec 2020 |
3,936 |
0
|
-
|
|
-
|
Options to purchase Common Stock |
Aristippos Gennadios
|
President Softgel & Oral Tech |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.44 per share. |
21 Dec 2020 |
3,936 |
55,361
(0%)
|
0%
|
24.4 |
96,196
|
Common Stock |
Aristippos Gennadios
|
President Softgel & Oral Tech |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.02 per share. |
21 Dec 2020 |
9,726 |
61,151
(0%)
|
0%
|
36.0 |
350,331
|
Common Stock |
Aristippos Gennadios
|
President Softgel & Oral Tech |
Sale of securities on an exchange or to another person at price $ 102.95 per share. |
21 Dec 2020 |
3,936 |
51,425
(0%)
|
0%
|
102.9 |
405,211
|
Common Stock |
John R. Chiminski
|
Director, Chair & CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
17 Dec 2020 |
10,000 |
163,618
(0%)
|
0%
|
|
0
|
Common Stock |
Peter Zippelius
|
Director |
|
23 Nov 2020 |
5,392,280 |
5,392,280
(3%)
|
3%
|
49.5 |
267,138,404
|
Common Stock |
Peter Zippelius
|
Director |
|
23 Nov 2020 |
265,223 |
384,777
|
-
|
|
-
|
Series A Convertible Preferred Stock |
Peter Zippelius
|
Director |
Sale of securities on an exchange or to another person at price $ 99.26 per share. |
23 Nov 2020 |
5,392,280 |
0
(0%)
|
3%
|
99.3 |
535,237,713
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 100.99 per share. |
11 Nov 2020 |
2,425 |
73,496
(0%)
|
0%
|
101.0 |
244,901
|
Common Stock |
Donald E. Morel
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Oct 2020 |
2,125 |
52,911
(0%)
|
0%
|
|
0
|
Common Stock |
Jack L. Stahl
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Oct 2020 |
2,125 |
30,777
(0%)
|
0%
|
|
0
|
Common Stock |
Gregory T. Lucier
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Oct 2020 |
2,125 |
19,707
(0%)
|
0%
|
|
0
|
Common Stock |
John J. Greisch
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Oct 2020 |
2,125 |
11,329
(0%)
|
0%
|
|
0
|
Common Stock |
Rolf A. Classon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Oct 2020 |
2,125 |
30,777
(0%)
|
0%
|
|
0
|
Common Stock |
Madhu Balachandran
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Oct 2020 |
2,125 |
14,897
(0%)
|
0%
|
|
0
|
Common Stock |
Rosemary A. Crane
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Oct 2020 |
2,125 |
11,329
(0%)
|
0%
|
|
0
|
Common Stock |
J. Martin Carroll
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Oct 2020 |
2,125 |
18,108
(0%)
|
0%
|
|
0
|
Common Stock |
Christa Kreuzburg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Oct 2020 |
2,125 |
8,765
(0%)
|
0%
|
|
0
|
Common Stock |
Peter Zippelius
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Oct 2020 |
2,125 |
6,428
(0%)
|
0%
|
|
0
|
Common Stock |
Ricardo Pravda
|
SVP & Chief HR Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Oct 2020 |
2,249 |
13,948
(0%)
|
0%
|
|
0
|
Common Stock |
Kay A Schmidt
|
SVP, Technical Operations |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.02 per share. |
23 Oct 2020 |
425 |
15,339
(0%)
|
0%
|
94.0 |
39,959
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Oct 2020 |
11,539 |
0
|
-
|
|
-
|
Options to purchase Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Oct 2020 |
3,486 |
0
|
-
|
|
-
|
Options to purchase Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 94.33 per share. |
14 Oct 2020 |
500 |
75,921
(0%)
|
0%
|
94.3 |
47,165
|
Common Stock |
Steven L. Fasman
|
SVP & General Counsel |
Sale of securities on an exchange or to another person at price $ 92.28 per share. |
14 Oct 2020 |
568 |
76,421
(0%)
|
0%
|
92.3 |
52,415
|
Common Stock |